Crossmark

A novel protein encoded by circCOPA inhibits the malignant phenotype of glioblastoma cells and increases their sensitivity to temozolomide by disrupting the NONO–SFPQ complex

Crossref DOI link: https://doi.org/10.1038/s41419-024-07010-z

Published Online: 2024-08-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peng, Dazhao

Wei, Cheng

Jing, Boyuan

Yu, Runze

Zhang, Zhenyu https://orcid.org/0000-0002-4686-9241
Han, Lei https://orcid.org/0000-0002-0707-5027
License Information

Text and Data Mining valid from 2024-08-25

Version of Record valid from 2024-08-25
More Information

Article History

Received: 24 April 2024

Revised: 10 August 2024

Accepted: 16 August 2024

First Online: 25 August 2024

Competing interests

: The authors declare no competing interests.

: This study was approved by the Human Scientific Ethics Committee of the First Affiliated Hospital of Zhengzhou University, and written informed consent was obtained from all patients.

Document is current

Any future updates will be listed below